These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2220314)

  • 1. Transient global amnesia and Raynaud's phenomenon in scleroderma.
    Nishida A; Kaiya H; Uematsu M; Maeda M; Mori S; Wakabayashi S
    Acta Neurol Scand; 1990 Jun; 81(6):550-2. PubMed ID: 2220314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine and systemic scleroderma.
    Goldberg NC; Duncan SC; Winkelmann RK
    Arch Dermatol; 1978 Apr; 114(4):550-1. PubMed ID: 646367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleroderma and Raynaud's phenomenon.
    BARNETT AJ
    Clin Rep; 1959; 9():33-74. PubMed ID: 13796900
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.
    Kahan A; Amor B; Menkes CJ
    Ann Rheum Dis; 1985 Jan; 44(1):30-3. PubMed ID: 3882061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cold and emotional stress in Raynaud's disease and scleroderma.
    Freedman RR; Ianni P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's syndrome; acrosclerosis; scleroderma.
    JABLONSKA S; BUBNOW B; LUKASIAK B
    Br J Dermatol; 1958 Feb; 70(2):37-43. PubMed ID: 13510539
    [No Abstract]   [Full Text] [Related]  

  • 10. Raynaud's phenomenon in limited cutaneous systemic sclerosis.
    Bonnecaze AK
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26715139
    [No Abstract]   [Full Text] [Related]  

  • 11. Paroxysmal dysarthria and Raynaud's phenomenon in the tongue.
    Nielsen HV; Kristensen JK; Klemp P; Staberg B; Thomsen K
    Acta Med Scand; 1984; 216(4):431-2. PubMed ID: 6516913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's phenomenon affecting the tongue of a patient with scleroderma.
    Bridges MJ; Kelly CA
    Ann Rheum Dis; 2002 May; 61(5):472. PubMed ID: 11959778
    [No Abstract]   [Full Text] [Related]  

  • 14. Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon.
    Bunker CB; Terenghi G; Springall DR; Polak JM; Dowd PM
    Lancet; 1990 Dec 22-29; 336(8730):1530-3. PubMed ID: 1979366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted high concentration botulinum toxin A injections in patients with Raynaud's phenomenon: a retrospective single-centre experience.
    Nagarajan M; McArthur P
    Rheumatol Int; 2021 May; 41(5):943-949. PubMed ID: 32447423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Raynaud's phenomenon and systemic scleroderma].
    Fiessinger JN; Housset E
    Rev Prat; 1975 May; 25(25):1989-92, 1997-8. PubMed ID: 1135587
    [No Abstract]   [Full Text] [Related]  

  • 18. [Raynaud's phenomenon and scleroderma (author's transl)].
    Merlen JF
    Ann Cardiol Angeiol (Paris); 1980 Jun; 29(4):333-7. PubMed ID: 7447353
    [No Abstract]   [Full Text] [Related]  

  • 19. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.